The influence of catalyst in reaction 56621-48-8

The article 《Synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxypropyl]-pyrrolidin-2-one derivatives with anti-arrhythmic, hypotensive, and α-adrenolytic activity》 also mentions many details about this compound(56621-48-8)Safety of 4-(Piperazin-1-yl)phenol, you can pay attention to it, because details determine success or failure

Heterocyclic compounds can be divided into two categories: alicyclic heterocycles and aromatic heterocycles. Compounds whose heterocycles in the molecular skeleton cannot reflect aromaticity are called alicyclic heterocyclic compounds. Compound: 56621-48-8, is researched, Molecular C10H14N2O, about Synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxypropyl]-pyrrolidin-2-one derivatives with anti-arrhythmic, hypotensive, and α-adrenolytic activity, the main research direction is piperazine pyrrolidinone preparation antiarrhythmic hypotensive adrenolytic SAR.Safety of 4-(Piperazin-1-yl)phenol.

A series of novel arylpiperazines bearing a pyrrolidin-2-one fragment was synthesized and evaluated for the binding affinity of the α1- and α2-adrenoceptors (AR) and for the antiarrhythmic and hypotensive activities of the compounds The most potent and selective compound 1-[2-hydroxy-3-[4-[(2-hydroxyphenyl)piperazin-1-yl]propyl]pyrrolidin-2-one 8 binds with pKi = 6.71 for α1-AR. Derivative 8 (I) was also the most active in the prophylactic antiarrhythmic test in adrenaline-induced arrhythmia in anesthetized rats. Its ED50 value equals 1.9 mg/kg (i.v.). Compounds with substituents such as a fluorine atom 4, a Me 5, or a hydroxyl 8 group, or two substituents such as fluorine/chlorine atoms and methoxy groups in the Ph ring, significantly decreased the systolic and diastolic pressure in normotensive anesthetized rats at a dosages of 5-10 mg/kg (i.v.). It was found that the presence of the piperazine ring and a hydroxy group in the second position of the Pr chain are critical structural features in determining the affinity of the compounds tested.

The article 《Synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxypropyl]-pyrrolidin-2-one derivatives with anti-arrhythmic, hypotensive, and α-adrenolytic activity》 also mentions many details about this compound(56621-48-8)Safety of 4-(Piperazin-1-yl)phenol, you can pay attention to it, because details determine success or failure

Reference:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem